↓ Skip to main content

Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer

Overview of attention for article published in BMC Cancer, April 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
Published in
BMC Cancer, April 2014
DOI 10.1186/1471-2407-14-303
Pubmed ID
Authors

Salvatore Micali, Stefania Bulotta, Cinzia Puppin, Angelo Territo, Michele Navarra, Giampaolo Bianchi, Giuseppe Damante, Sebastiano Filetti, Diego Russo

Abstract

Expression and function of sodium iodide symporter (NIS) is requisite for efficient iodide transport in thyrocytes, and its presence in cancer cells allows the use of radioiodine as a diagnostic and therapeutic tool in thyroid neoplasia. Discovery of NIS expression in extrathyroidal tissues, including transformed cells, has opened a novel field of research regarding NIS-expressing extrathyroidal neoplasia. Indeed, expression of NIS may be used as a biomarker for diagnostic, prognostic, and therapeutic purposes. Moreover, stimulation of endogenous NIS expression may permit the radioiodine treatment of extrathyroidal lesions by concentrating this radioisotope.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 2%
Unknown 54 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 16%
Student > Bachelor 8 15%
Student > Ph. D. Student 7 13%
Professor 4 7%
Student > Doctoral Student 3 5%
Other 10 18%
Unknown 14 25%
Readers by discipline Count As %
Medicine and Dentistry 18 33%
Biochemistry, Genetics and Molecular Biology 10 18%
Agricultural and Biological Sciences 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Nursing and Health Professions 2 4%
Other 2 4%
Unknown 16 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2014.
All research outputs
#18,371,293
of 22,754,104 outputs
Outputs from BMC Cancer
#5,419
of 8,275 outputs
Outputs of similar age
#164,142
of 227,058 outputs
Outputs of similar age from BMC Cancer
#89
of 131 outputs
Altmetric has tracked 22,754,104 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,275 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,058 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 131 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.